phio pharmaceuticals corp., a biotechnology company, develops immuno-oncology therapeutics in the united states. it offers intasyl therapeutic platform focuses on silencing tumor-induced suppression of the immune system. the company develops ph-762 which t

Phio Pharmaceuticals Corp. Common Stock

Sold all PHIO

This member connected a brokerage account and is sharing trades and portfolio performance with the community. 

Public Portfolio

Braxton Crane

Mike Pelech

New position in PHIO

Zachary Rapp

Sold 99% of PHIO

ParkerB

Bought 10000% more PHIO

Lemuel

Sold 50% of PHIO

Adeleon3

Anomity

Bought 100% more PHIO